Figure 3.
In the third-line cetuximab group, Kaplan–Meier curves of OS and PFS are illustrated stratified by with or without prior bevacizumab.
Notes: (A) OS for patients receiving cetuximab as third line. (B) PFS for patients receiving cetuximab as third line.
Abbreviations: OS, overall survival; PFS, progression-free survival.